Navigation Links
TorreyPines Therapeutics Reports First Quarter 2009 Financial Results
Date:5/1/2009

LA JOLLA, Calif., May 1 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) today reported financial results for the first quarter ended March 31, 2009. For the three-month period, the company posted a net loss of $2.1 million. Cash and cash equivalents totaled $6.3 million at March 31, 2009.

On April 15, 2009, the Company hired Merriman Curhan Ford as its financial advisor to assist in the evaluation of strategic options, including the possible sale of the Company or its assets.

Financial Results

Revenue for the three month period ended March 31, 2009 was $0 compared to revenue of $2.0 million for the same period in 2008. Operating expenses for the quarter ended March 31, 2009 were $2.1 million, with $0.9 million attributable to research and development. This compares to operating expenses of $6.7 million and research and development expenses of $5.3 million for the same period last year. The company reported a net loss for the quarter ended March 31, 2009 of $2.1 million compared to a net loss of $3.9 million for the previous year.

About TorreyPines Therapeutics

TorreyPines Therapeutics, Inc. is a biopharmaceutical company committed to providing patients with better alternatives to existing therapies through the development and commercialization of small molecule compounds. The company's goal is to develop versatile product candidates each capable of treating a number of acute and chronic diseases and disorders such as migraine, acute and chronic pain, and xerostomia. The company currently has three clinical stage product candidates: two ionotropic glutamate receptor antagonists and one muscarinic receptor agonist. Further information is available at www.tptxinc.com.

This press rel
'/>"/>

SOURCE TorreyPines Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. TorreyPines Therapeutics to Present at the NewsMakers in the Biotech Industry Conference
2. TorreyPines Therapeutics to Present at ThinkEquitys G5 Conference
3. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
4. TorreyPines Therapeutics to Present at ThinkEquitys ThinkClinic Conference
5. TorreyPines Therapeutics to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. TorreyPines Therapeutics Reports Third Quarter 2007 Results
7. TorreyPines Therapeutics to Present at Susquehanna Financial Groups Second Annual SIGnificant Options in Healthcare Conference
8. TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia
9. TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights
10. TorreyPines Therapeutics to Host First Quarter 2008 Results Conference Call and Webcast
11. TorreyPines Therapeutics to Present Tezampanel Phase IIb Clinical Data for Acute Migraine at 50th Annual Scientific Meeting of the American Headache Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... carbon nanotubes is neat, but Rice University scientists are making ... new fibers created at Rice line up like a fistful ... Mart and his colleagues. , The tricky bit, according to ... journal ACS Nano , is keeping the densely packed ... Left to their own devices, carbon nanotubes form clumps that ...
(Date:9/15/2014)... -- Research and Markets has announced the addition ... Services, by Technology, by Application - Global Forecast to 2018" ... Sequencing (WES) is next-generation technology used for strategically sequencing the ... which is the total of all exons of an organism, ... converted into proteins after translation. It is responsible for the ...
(Date:9/15/2014)... , 15 de septiembre de 2014 La ... llevará a cabo del 12 al 18 de octubre. Como ... (PPTA) y de sus compañías miembro s, la IPAW ... concienciación mundial en torno a la colección de fuentes de ... de plasma al salvar y mejorar las vidas , ...
(Date:9/14/2014)... when it comes to survival strategies. They often create ... for example during treatment with antibiotics. A biofilm is ... slime capsule consisting of sugar chains and "curli". ... the first time created a detailed three-dimensional image of ... the bacterial cell wall, a crucial step in the ...
Breaking Biology Technology:Rice rolls 'neat' nanotube fibers 2Rice rolls 'neat' nanotube fibers 3Global Whole Exome Sequencing (Systems, Kits, Library Preparation, Target Enrichment) Market by Product, by Services, by Technology, by Application - Forecast to 2018 2Global Whole Exome Sequencing (Systems, Kits, Library Preparation, Target Enrichment) Market by Product, by Services, by Technology, by Application - Forecast to 2018 3La International Plasma Awareness Week será una celebración para los donantes 2La International Plasma Awareness Week será una celebración para los donantes 3New insights in survival strategies of bacteria 2
... that the economy is not,only heading towards a recession ... mood during January. However, biotech held steady,with the Burrill ... which posted a January loss of 9.9%, and the ... to ride out extremely volatile capital,markets with less damage ...
... BODY WORLDS 2:,The Original Exhibition of Real Human ... Saturday, February 2nd. The acclaimed exhibition,includes the East ... special feature on,the brain., BODY WORLDS presents ... and unhealthy organs, body section and slices, all,preserved ...
... Pollard Brings the Highest Level of Clinical Immunology ... 1 Genetic,Immunity(R), a US/Hungarian clinical-stage biopharmaceutical company,focused ... platform technology, announced that it has appointed,Richard B. ... Pollard has been a leader in HIV/AIDS research ...
Cached Biology Technology:January Market Jitters Fails to Derail Biotech 2January Market Jitters Fails to Derail Biotech 3January Market Jitters Fails to Derail Biotech 4Maryland Science Center Unveils Anatomical Exhibition, Body Worlds 2, on Saturday, February 2 2Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer 2Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer 3
(Date:9/15/2014)... Sugar is a vital source of energy for both ... makes its way into the cell could lead to ... an increase in the amount of fruits and vegetables ... recently uncovered one of these "pathways" into the cell ... of a strand of spider silk. , To determine ...
(Date:9/15/2014)... of Australia,s leading coral reef ecologists fears that reef ... ecosystem survival that we once thought. , In an ... ARC Centre of Excellence for Coral Reef Studies (Coral ... most important species within reef ecosystems. , In coral ... vital jobs that keep the ecosystem safe and functioning. ...
(Date:9/15/2014)... Earth for the first 500 million years after it ... day, complete with oceans, continents and active crustal plates. ... called the Hadean, has gained substantial new support from ... more than 4 billion years ago with those formed ... possible geological analog for early Earth. , The study ...
Breaking Biology News(10 mins):X-rays unlock a protein's SWEET side 2X-rays unlock a protein's SWEET side 3Specialized species critical for reefs 2Early Earth less hellish than previously thought 2Early Earth less hellish than previously thought 3
... dozens of shark species living in the coastal waters off ... the species, but a survey begun nearly 25 years ago ... populations and their role in marine ecosystems. NOAA scientists ... R.I., recently conducted their ninth coastal shark survey from Florida ...
... colorful leaves adorning the trees are a delight to the ... the United States and East Asia boast lustrous red foliage. ... autumnal hues around the world? A new theory provided by ... at the University of Haifa-Oranim and Prof. Jarmo Holopainen of ...
... team of researchers from Boston University, Harvard Medical School ... that changes a long held paradigm about how bacteria ... that causes human stomach ulcers uses a clever biochemical ... allowing it to move and survive and further colonize ...
Cached Biology News:Scientists conduct shark survey off US East Coast 2Scientists conduct shark survey off US East Coast 3Why are autumn leaves red in America and yellow in Europe? 2Why are autumn leaves red in America and yellow in Europe? 3Uncovering the secrets of ulcer-causing bacteria 2
... microarrays are derived from Paraffin embedded tissue ... control procedures to ensure the highest quality. ... in one block, sectioned at a thickness ... slides. Sections are large (3-5 mm in ...
ID clarifier: platform...
StemSep Anti-Phycoertherin Tetrameric Antibody Complexes, 2 mL for labeling 1x10 9 cells. Cross-linking Reagent for StemSep Separations of Cells Labeled with PE-conjugated Antibody....
... The PROTEAN II xi multi-cell is for 2-D ... efficient cooling capabilities. The PROTEAN II xi multi-cell ... comb, type of glass plates, and cooling system. ... converted to the PROTEAN II XL multi-cell for ...
Biology Products: